Table 2.
Study Title | Information provided by (Responsible Party): | ClinicalTrials.gov Identifier | |
---|---|---|---|
1 | Mesenchymal Stem Cells Transplantation in Newly Diagnosed Type-1 Diabetes Patients (MSCTXT1DM) | Tehran University of Medical SciencesIranian StemCell Council | NCT04078308 |
2 | Mesenchymal Stem Cells for Progressive Multiple Sclerosis Sweden | Ellen Iacobaeus, Karolinska Institutet | NCT03778333 |
3 | Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD | National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | NCT02824653 |
4 | Bone Regeneration With Mesenchymal Stem Cells | Alejandro Gonzalez-Ojeda, Instituto Mexicano del Seguro Social | NCT02755922 |
5 | Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in Participants With Crohn's Disease (RVF) | Amy Lightner, The Cleveland Clinic | NCT04519697 |
6 | Mesenchymal Stem Cell Transplantation for Acute-on-chronic Liver Failure | Han Ying, Xijing Hospital of Digestive Diseases | NCT03668171 |
7 | Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19 | Martín Iglesias, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | NCT04416139 |
8 | Clinical Trial of Umbilical Cord Mesenchymal Stem Cell Transfusion in Decompensated Liver Cirrhosis | Shandong Qilu Stem Cells Engineering Co., Ltd | NCT03529136 |
9 | Mesenchymal Stem Cells for Multiple Sclerosis | Ellen Iacobaeus, Karolinska Institutet | NCT01730547 |
10 | Use of Mesenchymal Stem Cells in Inflammatory Bowel Disease | Hanan Jafar, University of Jordan | NCT03299413 |
11 | Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease | Stemedica Cell Technologies, Inc | NCT02833792 |
12 | Allogeneic Human Cells (hMSC) Via Intravenous Delivery in Patients With Mild Asthma (ASTEC) | Marilyn Glassberg, University of Miami | NCT03137199 |
GVHD Graft Versus Host Disease, RVF Rectovaginal Fistulas, hMSC Human Mesenchymal Stem cell